Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
1.870
+0.030 (1.63%)
At close: Jun 23, 2026, 4:00 PM EDT
1.810
-0.060 (-3.19%)
After-hours: Jun 23, 2026, 6:37 PM EDT
Inhibikase Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Mazahir Alimohamed Oppenheimer No rating | Oppenheimer | Buy Initiates $5 | Buy | Initiates | $5 | +167.38% | Jun 10, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $6 | Buy | Reiterates | $6 | +220.86% | Jun 3, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $8 | Buy | Reiterates | $8 | +327.81% | May 26, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $4 | Buy | Maintains | $4 | +113.90% | May 19, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $5 | Buy | Maintains | $5 | +167.38% | May 16, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $8 | Buy | Maintains | $8 | +327.81% | May 15, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Initiates $4 | Buy | Initiates | $4 | +113.90% | Mar 4, 2026 |